The role of neuropeptides and capsaicin-sensitive fibres in glutamate-induced nociception and paw oedema in mice

Brain Res. 2003 Apr 18;969(1-2):110-6. doi: 10.1016/s0006-8993(03)02286-8.

Abstract

This study sought to establish whether sensory neuropeptides and the capsaicin-sensitive fibres are involved in the nociception and oedema formation caused by intraplantar (i.pl.) injection of glutamate into the mouse paw. The i.pl. co-injection of the selective neurokinin (NK) NK(2) (SR 48968, 0.05-0.5 nmol/paw), and to a lesser extent the selective NK(1) (FK 888, 0.25-1.0 nmol/paw) receptor antagonists, resulted in a significant inhibition of glutamate-induced nociception. The percentages of inhibition were 82 and 37%, respectively. In contrast, the selective NK(3) receptor antagonist (SR 142801, 0.25-1.0 nmol/paw) failed to significantly affect glutamate-induced nociception. SR 48968, but not FK 888 or SR 142801, significantly inhibited (36%) glutamate-induced paw oedema formation. The i.pl. injection of kinin B(1) receptor antagonist des-Arg(9)-[Leu(8)]-BK (0.2-0.8 nmol/paw), but not the B(2) receptor antagonist HOE 140 (1.0-4.0 nmol/paw), together with glutamate, also inhibited glutamate-induced nociception (53%) in a graded manner, without affecting glutamate-induced paw oedema. The i.pl. co-injection of the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) (1 nmol/paw) failed to significantly inhibit glutamate-induced nociception or oedema. Finally, neonatal-capsaicin (50 mg/kg, s.c.) treatment inhibited glutamate-induced nociception by 69% and to a lesser extent glutamate-mediated oedema formation (30%). Collectively, the current results indicate that the nociception caused by i.pl. injection of glutamate in mice is clearly mediated by capsaicin-sensitive fibres and by release of neurokinins from sensory neurones that activate NK(2) receptors and to a lesser extent NK(1) receptors. Furthermore, kinins acting at B(1) (but not at B(2)) receptors also largely account for glutamate-mediated nociceptive behaviour response. In contrast, glutamate-induced paw oedema seems to be primarily mediated via activation of NK(2) receptors and stimulation of capsaicin-sensitive C-fibres. CGRP receptors do not seem to be involved in either of the glutamate responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • Bradykinin Receptor Antagonists
  • Calcitonin Gene-Related Peptide / metabolism
  • Capsaicin / metabolism
  • Capsaicin / pharmacology
  • Dipeptides / pharmacology
  • Edema / chemically induced
  • Edema / physiopathology*
  • Foot / physiopathology
  • Glutamic Acid / pharmacology*
  • Indoles / pharmacology
  • Male
  • Mice
  • Nerve Fibers / drug effects
  • Nerve Fibers / physiology*
  • Neurokinin-1 Receptor Antagonists
  • Nociceptors / drug effects
  • Nociceptors / physiology*
  • Pain / physiopathology*
  • Piperidines / pharmacology
  • Receptor, Bradykinin B1
  • Receptor, Bradykinin B2
  • Receptors, Calcitonin Gene-Related Peptide / metabolism
  • Receptors, Neurokinin-1 / drug effects
  • Receptors, Neurokinin-1 / metabolism
  • Receptors, Neurokinin-2 / antagonists & inhibitors
  • Receptors, Neurokinin-2 / drug effects
  • Receptors, Neurokinin-2 / metabolism

Substances

  • Benzamides
  • Bradykinin Receptor Antagonists
  • Dipeptides
  • Indoles
  • Neurokinin-1 Receptor Antagonists
  • Piperidines
  • Receptor, Bradykinin B1
  • Receptor, Bradykinin B2
  • Receptors, Calcitonin Gene-Related Peptide
  • Receptors, Neurokinin-1
  • Receptors, Neurokinin-2
  • FK 888
  • Glutamic Acid
  • SR 48968
  • Calcitonin Gene-Related Peptide
  • Capsaicin